TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from HCW Biologics ( (HCWB) ).
On November 18, 2025, HCW Biologics announced the dosing of the first patient in a Phase 1 clinical trial for its lead product candidate, HCW9302, aimed at treating alopecia areata, an autoimmune disorder. This trial marks a significant milestone in the company’s efforts to develop treatments for autoimmune diseases, with HCW9302 showing potential to activate regulatory T cells to reduce inflammation without broad immunosuppression. The study aims to establish a safe dose for Phase 2 trials, with future plans to explore HCW9302’s efficacy in other inflammatory conditions.
The most recent analyst rating on (HCWB) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on HCW Biologics stock, see the HCWB Stock Forecast page.
Spark’s Take on HCWB Stock
According to Spark, TipRanks’ AI Analyst, HCWB is a Underperform.
HCW Biologics is facing significant financial and operational challenges, with declining revenues and high leverage. Technical indicators suggest bearish momentum, and valuation metrics highlight ongoing losses. These factors contribute to a low overall stock score, indicating a high-risk investment with substantial hurdles to overcome.
To see Spark’s full report on HCWB stock, click here.
More about HCW Biologics
HCW Biologics Inc. is a U.S.-based clinical-stage biopharmaceutical company that focuses on developing innovative immunotherapies to treat diseases associated with chronic inflammation, such as cancer, autoimmune diseases, and neurodegenerative diseases. The company leverages its proprietary TOBI and TRBC platform technologies to create a new class of drugs aimed at improving patients’ quality of life and potentially extending longevity.
Average Trading Volume: 1,888,871
Technical Sentiment Signal: Sell
Current Market Cap: $6.45M
See more data about HCWB stock on TipRanks’ Stock Analysis page.